Validation of the R-ISS and IMWG-2014 classification in multiple myeloma patients undergoing high dose melphalan autologous stem cell transplant registered with the CIBMTR.
Study #: MM16-01a
Study Status: Published
Presentation(s)
2017, ASH (Poster)
Staging systems for newly diagnosed myeloma patients undergoing autologous hematopoietic cell transplantation: The revised international staging system shows the most differentiation between groups.
Citation
Scott EC, Hari P, Kumar S, Fraser R, Davila O, Shah N, Gale RP, Diaz MA, Agrawal V, Cornell RF, Ganguly S, Akpek G, Freytes C, Hashmi S, Malek E, Kamble RT, Lazarus H, Solh M, Usmani SZ, Kanate AS, Saad A, Chhabra S, Gergis U, Cerny J, Kyle RA, Lee C, Kindwall-Keller T, Assal A, Hildebrandt GC, Holmberg L, Maziarz RT, Nishihori T, Seo S, Kumar S, Mark T, D'Souza A.
Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2018, Dec 01: 24(12): 24(12):2443-2449. doi: 10.1016/j.bbmt.2018.08.013. Epub 2018, Aug 22. PMCID:PMC6293469.
PubMed
PMID: 30142419
Abstract